OpenVSafe by OpenVAERS
Search V-safe

VHQ-57966-47047

2 vaccinations 3 coded responses 11 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
079 / NJ
Registered
2021-01-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-13
    Registered in v-safe
  2. 2021-01-13
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains, Fatigue or tiredness, Abdominal pain
    Adult check-in
  5. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2021-01-21
    Health check-in — 7 day, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-27
    Health check-in — 14 day, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-02-03
    Dose 2 — Pfizer-BioNTech
  9. 2021-02-03
    Survey response — 0 day, dose 2
    MedDRA: Disturbance in attention, Dizziness, Feeling abnormal — Feeling: Poor · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  10. 2021-02-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Unevaluable event — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  11. 2021-02-04
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-02-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  13. 2021-02-10
    Health check-in — 7 day, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-19
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-05
    Health check-in — 3 month, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-30

Vaccinations

DoseDateManufacturerCo-administered
12021-01-13Pfizer-BioNTech
22021-02-03Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-02-04 Unsuccessful

Free text

Release 3

Systemic reaction (other): Brain fog, dizziness m, difficulty paying attention

Systemic reaction (other): Possible miscarriage
Healthcare visit (other): Got labs drawn

Systemic reaction (other): Swollen lymph nodes

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SRODisturbance in attention ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release